Roche Chooses BWise for Internal Control for Financial Reporting
Basel, Switzerland, June 27, 2006 – BWise, a leading provider of compliance and enterprise risk management software, today announced that Roche Corporate Finance & Accounting, one of the world's leading research-based healthcare companies, has chosen BWise to support its Internal Control for Financial Reporting (ICFR) project. The BWise solution will be implemented at the corporate level as well as among various local levels.
Roche is a leading healthcare company with an uniquely broad spectrum of innovative solutions. For more than 100 years, Roche has been actively involved in the discovery, development, manufacturing and marketing of novel healthcare solutions. Roche’s uniquely designed products and services address the prevention, diagnosis and treatment of diseases, thus enhancing well-being and quality of life. The BWise compliance software will assist Roche in meeting and tracking ICFR compliance and process improvement requirements across its corporate enterprise and various businesses.
“BWise is pleased to have the opportunity to support Roche and meet its internal control for financial reporting objectives,” said Robert Pijselman, Chief Executive Officer of BWise. “With BWise, Roche can establish an easy-to-use and scalable system for streamlining governance efficiencies across its expansive network of utilities and related businesses.”
“Roche was looking for a solution not only to facilitate our ICFR objectives, but also to enable us to realize important process improvements,” stated Philippe Muller, ICFR Project Manager of Roche. “With the BWise solution, we are able to meet the specified requirements more efficiently on all levels.”
# # #
BWise is a global leader in compliance and enterprise risk management software, with a strong heritage in business process management. Established in 1994, BWise delivers proven solutions to help organizations become “in control” by increasing corporate accountability; strengthening financial, strategic and operational efficiencies; and maximizing performance and ROI. With more than 1,200 customers in more then 80 countries worldwide and 125,000 users in virtually all markets, BWise has developed a strong and sustainable presence in the compliance and risk management sectors. Utilizing templates and a best-practice implementation approach, BWise enables management to measure and manage risks and to comply to rules and legislation such as Sarbanes-Oxley, European Corporate Governance Codes, IFRS, Basel II, ISO-standards and more. BWise has offices in the Netherlands, United States and India. For more information, visit http://www.bwise.com.
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people’s health and quality of life. Roche is a world leader in diagnostics, the leading supplier of medicines for cancer and transplantation and a market leader in virology. In 2005 sales by the Pharmaceuticals Division totalled 27.3 billion Swiss francs, and the Diagnostics Division posted sales of 8.2 billion Swiss francs. Roche employs roughly 70,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. Additional information about the Roche Group is available on the Internet (www.roche.com).
Kim Larkin Philippe Muller
D. Larkin & Associates for BWise Roche
Office: (703) 250-3590 Office: +41 61 68 85834